Paid-members only

Markets Featured

The Alzheimer's Bottleneck Was Never the Drugs

The FDA just cleared the first blood test that can both confirm and rule out Alzheimer's pathology from a routine blood draw — in primary care, on analyzers already installed in 4,500 US labs. The $26,500-a-year drugs were never the constraint. The diagnosis was.

Paid-members only

Energy Featured

How America's Refineries Became the World's Single Point of Failure

US refineries have run above 95% capacity for 11 straight weeks — the longest stretch since 1998 — holding the global fuel market together after war took Iran and Russia offline. History says runs like this end suddenly. What breaks, and how to position for it.

Paid-members only

Markets Featured

$AAOI: An FCC Ban on Chinese Optics Just Created a 60% Market Gap. Can Applied Optoelectronics Fill It?

Applied Optoelectronics just posted its fifth straight record quarter on 86% revenue growth while the FCC drafts a ban that could restructure who builds the backbone of AI infrastructure. The numbers behind the setup are more complex than the headlines suggest.

Markets Featured

How Las Vegas Replaced the Tourists Who Stopped Coming

Las Vegas visitation looks stable again — but the tourists holding the line aren't the ones who left. Inside the customer swap that reprices the Strip, and what it reveals about the American consumer.

Members only

Markets Featured

10 Stocks Worth Watching This Week: Core PCE, Nvidia, and a Hawkish Jackson Hole — August 24–28, 2026

Core PCE lands Wednesday morning, Nvidia reports that night, and the first Warsh-era Jackson Hole opens Thursday — with markets pricing hike risk, not cuts. Ten stocks positioned around the week's catalysts.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Monday, August 24

Uranium breaks out on nuclear demand, rare earth names surge on supply-chain urgency, PDD and XPeng both report Q2 this morning. Ten names with the clearest setups and hardest catalysts heading into Monday's open.

Paid-members only

Finance Featured

Can Bessent Cap the Long Bond Without the Fed?

The Treasury doubled its long-bond buybacks to stop a selloff — and the rally lasted 48 hours. What the failed intervention reveals about who actually controls the long end, and what Warsh's Jackson Hole debut now has to decide.

Finance Featured

Why Costco Is Walking Into the Market Health Insurers Are Fleeing

UnitedHealth, Humana, and Aetna are cutting Medicare Advantage by the hundreds of counties. Costco just entered the $500 billion market — with a deal structured so the retailer can't lose.

Paid-members only

AI Featured

Marvell Just Paid Google to Buy Its Chips

Marvell handed Google warrants on $12.2 billion of its own stock as a reward for chip orders — the second time in a year an AI supplier has paid its customer in equity. The math behind the new price of hyperscaler business.

Finance Featured

Three Industries Are Paying for the Most Expensive Midterms in History

The all-time record for corporate election spending fell in March — seven months before a single midterm vote. The money isn't coming from oil, pharma, or banks: crypto, AI, and sportsbooks are buying the regulatory map.

Paid-members only

Markets Featured

Who Sells Poland When It Stops Being Emerging?

S&P Dow Jones just handed Poland the decade's first promotion out of emerging markets. The reward: losing its biggest required buyers. Inside the graduation trade — the flows timeline, the MSCI catalyst, and the names that benefit.

Paid-members only

Defence Featured

Can Raytheon Build 1,000 Tomahawks a Year?

Raytheon builds roughly 60 Tomahawks a year. A $22.9 billion, seven-year Pentagon contract just ordered more than 1,000 — and quietly rewrote the business model of the American munitions industry. Who gets paid for the buildout.

Markets Featured

Why Every Delivery App Suddenly Wants Its Own Air Force

Amazon is scaling drone delivery sixfold to nearly 500 cities, Walmart and Wing are adding 150 stores, and DoorDash just won its own FAA air-carrier certificate. The land grab for America's low-altitude airspace has started — and the deadline is a rule the FAA hasn't published yet.

Paid-members only

Geopolitics Featured

China Is Annexing the South China Sea With Paperwork

A nature reserve, a stack of ecological reports, and an empty ocean: while America's Iran war pulls the last carrier from the Pacific, China is annexing Scarborough Shoal with administrative law — and markets price the world's busiest trade artery at zero risk.

Paid-members only

Finance Featured

The Hackers Picking Off Private Equity One Phone Call at a Time

Hackers just walked out of a $938 billion asset manager with a phone call and a fake login page. The targeting shift behind the Apollo breach reprices operational risk for private equity — and hands the mandate to a short list of identity-security names.

Paid-members only

Investing Featured

$LUNR: Intuitive Machines Hit a $1.8B Backlog. Now the Hard Math Starts.

Intuitive Machines quadrupled Q2 revenue to $206M and landed a $600M satellite deal. With 27% of the float short and $481M in debt, the bull case depends on math the stream hasn't done.

Paid-members only

Energy Featured

Hoover Dam Is Five Feet From Losing Most of Its Power

Lake Mead just broke its 1930s-era record low and sits five feet above the elevation where Hoover Dam loses 12 of its 17 turbines. Upstream, Glen Canyon Dam may stop generating entirely within months. The Southwest's cheapest electricity is vanishing — here's who pays, and who collects.

Members only

Markets Featured

India Is Letting the Rupee Go

The RBI has sold $53 billion and let reserves fall nearly $40 billion from their peak to hold the rupee's line against a 50% US tariff wall. The evidence says it just stopped — and that decision reprices Indian assets more than any tariff headline.

Macro Featured

Where Did the Entry-Level Job Go?

Recent-grad unemployment is 5.7% and underemployment just hit its worst level since 2020. Everyone blames AI. The Fed's own data says the real culprit is something else — and which story is right decides whether rate cuts can fix it.

Paid-members only

Investing Featured

$MRNA: Moderna Just Made History Twice. Now the Market Has to Decide What It's Worth.

In two weeks, Moderna got the first mRNA flu vaccine approved in U.S. history and won the first successful Phase 3 for a personalized cancer vaccine. The stock moved 177% in a day. Here's what it's worth.

Paid-members only

Finance Featured

The Best Bonds of 2026 Bet That Inflation Never Left

The Global Agg has lost money this year. Broad EM local debt returned 1.5%. One $886 billion corner of the bond market returned 11.3% — by assuming inflation would stay. How the trade worked, and where the money is rotating next.

Paid-members only

Markets Featured

Why Corn Is Up 23% While Everyone Watches Oil

USDA just made a bigger-than-expected cut to the US corn yield, this week's crop tour is confirming a Corn Belt split between drought and flood, and exports are running 82% above last year. The quietest repricing of 2026 is in the dirt, not the strait.

Markets Featured

American Drug Prices Just Broke a 63-Year Record

Prescription drug prices are falling at the fastest annual rate since 1963 — seven straight months of deflation in a category that almost never deflates. Washington is fighting over the credit. The real question is who absorbs the cut.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Wednesday, August 19

Moderna surges 80%+ on FDA approval, Keysight beats by 24%, and the Iran blockade reshapes the energy and defense setup. Here are the 10 names worth watching today — with watch levels, trigger setups, and the afternoon FOMC catalyst mapped out.

Paid-members only

Markets Featured

$AMLX: Amylyx Just Won Its Phase 3. Now the Offering Changes the Math.

A 64% single-day surge on historic Phase 3 data. Then a $350 million equity raise announced the same evening. Here is what the dilution math, balance-sheet clock, and NDA calendar actually mean for the distribution of outcomes from here.